2014
DOI: 10.1007/s12028-014-0058-9
|View full text |Cite
|
Sign up to set email alerts
|

Lung-Protective Ventilation for SAH Patients: Are These Measures Truly Protective?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…For patients with GCS less than 9, the reported incidences were between 20 and 30% [ 13 , 49 51 ]. ALI and ARDS have been reported in 15–40% of patients suffering from an SAH [ 52 ], while the equivalent incidence for isolated TBI has been found to be about 20–25% [ 31 , 47 ].…”
Section: Lung Injuries In Acute Brain Damagementioning
confidence: 99%
See 1 more Smart Citation
“…For patients with GCS less than 9, the reported incidences were between 20 and 30% [ 13 , 49 51 ]. ALI and ARDS have been reported in 15–40% of patients suffering from an SAH [ 52 ], while the equivalent incidence for isolated TBI has been found to be about 20–25% [ 31 , 47 ].…”
Section: Lung Injuries In Acute Brain Damagementioning
confidence: 99%
“…Moreover, administration of vasoactive agents, a history of drug abuse, and hypertension have been described as additional risk parameters for the development of acute respiratory failure [ 7 , 47 ]. Finally, predictors of the development of ALI include older age, cardiac arrest, heart failure, chronic obstructive pulmonary disease, cardiovascular, renal or haematological dysfunction [ 55 ], sepsis, shock, transfusions, and pneumonia [ 52 ].…”
Section: Lung Injuries In Acute Brain Damagementioning
confidence: 99%
“…The hypothesized pathophysiology leading to the development of lung injury in aSAH patients is a “double-hit” model, with the first hit being an adrenergic surge and systemic inflammation incited by acute neurologic injury and the second from non-neurological stressors, such as infections, transfusions, and MV [ 21 23 ]. The best evidence for MV strategies to improve survival in ARDS involves lung-protective ventilation parameters described in an ARDS Network trial (ARDSNet) which includes tidal volumes of 6–8 mL/kg of predicted body weight to achieve a plateau pressure ≤ 30 cmH 2 O [ 24 ].…”
Section: Acute Respiratory Distress Syndrome In Asahmentioning
confidence: 99%